2

Bookmark and Share Cardiac Biomarkers: Technologies and Global Markets

bharatbook's site:
www.bharatbook.com

The global market for in vitro diagnostic tests for cardiac biomarkers was estimated at $3.1 billion in 2012 and nearly $4 billion in 2013. This market is predicted to reach $7.2 billion by 2018, at a compound annual growth rate (CAGR) of 12.8% over the five-year period from 2013 to 2018.

This report provides:

-An overview of the global market for biomarkers for cardiovascular disease (CVD) and related technologies.
-Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 to 2018.
-Classification of CVD by cerebrovascular, congestive, coronary, hypertensive, and peripheral arterial disease.
-Background and clinical values of cardiac biomarkers, including B-type natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP), choline, creatine kinase MB (CK-MB), D-dimer, glial fibrillary acidic protein (GFAP), heart fatty acid binding protein (H-FABP), ischemia-modified albumin (IMA), myeloperoxidase (MPO), myoglobin, soluble fragment CD40 ligand (sCD40L), and troponin I (cTnI)/troponin T (cTnT).
-Examination of the technology covering diagnostic methods, instrumentation, newly issued patents, and new patent applications.
-Clinical guidelines and government regulations.

 Read » Cardiac Biomarkers: Technologies and Global Markets

ahaf.org - American Health Assistance Foundation (AHAF)

Recent comments

Download and print the ultimate August 2014 calendar for free:
August 2014 Calendar
July 2014 calendar
August 2014 calendar